Buck S, Erickson-Oberg M, Logan R, Freyberg Z
Mol Psychiatry. 2022; 27(9):3583-3591.
PMID: 35681081
PMC: 9712151.
DOI: 10.1038/s41380-022-01649-w.
Perez S, Lodge D
J Neurosci. 2018; 38(50):10607-10618.
PMID: 30355626
PMC: 6290296.
DOI: 10.1523/JNEUROSCI.2629-16.2018.
McCullumsmith R, ODonovan S, Drummond J, Benesh F, Simmons M, Roberts R
Mol Psychiatry. 2015; 21(6):823-30.
PMID: 26416546
PMC: 7584379.
DOI: 10.1038/mp.2015.148.
McCollum L, Roberts R
Schizophr Res. 2015; 169(1-3):369-373.
PMID: 26386900
PMC: 4755276.
DOI: 10.1016/j.schres.2015.08.041.
ODonovan S, Hasselfeld K, Bauer D, Simmons M, Roussos P, Haroutunian V
Transl Psychiatry. 2015; 5:e579.
PMID: 26057049
PMC: 4490284.
DOI: 10.1038/tp.2015.74.
Transcript expression of vesicular glutamate transporters in lumbar dorsal root ganglia and the spinal cord of mice - effects of peripheral axotomy or hindpaw inflammation.
Malet M, Vieytes C, Lundgren K, Seal R, Tomasella E, Seroogy K
Neuroscience. 2013; 248:95-111.
PMID: 23727452
PMC: 3800240.
DOI: 10.1016/j.neuroscience.2013.05.044.
BDNF regulates the expression and distribution of vesicular glutamate transporters in cultured hippocampal neurons.
Melo C, Mele M, Curcio M, Comprido D, Silva C, Duarte C
PLoS One. 2013; 8(1):e53793.
PMID: 23326507
PMC: 3543267.
DOI: 10.1371/journal.pone.0053793.
Stress-induced deficits in cognition and emotionality: a role of glutamate.
Graybeal C, Kiselycznyk C, Holmes A
Curr Top Behav Neurosci. 2012; 12:189-207.
PMID: 22261703
PMC: 3877736.
DOI: 10.1007/7854_2011_193.
Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.
Marsman A, van den Heuvel M, Klomp D, Kahn R, Luijten P, Hulshoff Pol H
Schizophr Bull. 2011; 39(1):120-9.
PMID: 21746807
PMC: 3523901.
DOI: 10.1093/schbul/sbr069.
Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia.
Scorza F, Schmitt A, Cysneiros R, Arida R, Cavalheiro E, Gattaz W
Clinics (Sao Paulo). 2010; 65(5):539-46.
PMID: 20535373
PMC: 2882549.
DOI: 10.1590/S1807-59322010000500012.
Genetic inactivation of the vesicular glutamate transporter 2 (VGLUT2) in the mouse: what have we learnt about functional glutamatergic neurotransmission?.
Wallen-Mackenzie A, Wootz H, Englund H
Ups J Med Sci. 2010; 115(1):11-20.
PMID: 20187846
PMC: 2853350.
DOI: 10.3109/03009730903572073.
Executive function, neural circuitry, and genetic mechanisms in schizophrenia.
Eisenberg D, Berman K
Neuropsychopharmacology. 2009; 35(1):258-77.
PMID: 19693005
PMC: 2794926.
DOI: 10.1038/npp.2009.111.
Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.
Bauer D, Gupta D, Harotunian V, Meador-Woodruff J, McCullumsmith R
Schizophr Res. 2008; 104(1-3):108-20.
PMID: 18678470
PMC: 2656372.
DOI: 10.1016/j.schres.2008.06.012.
Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.
Steffek A, McCullumsmith R, Haroutunian V, Meador-Woodruff J
Schizophr Res. 2008; 103(1-3):71-82.
PMID: 18562176
PMC: 3774017.
DOI: 10.1016/j.schres.2008.04.032.
Synaptic vesicle protein trafficking at the glutamate synapse.
Santos M, Li H, Voglmaier S
Neuroscience. 2008; 158(1):189-203.
PMID: 18472224
PMC: 2667334.
DOI: 10.1016/j.neuroscience.2008.03.029.
Epigenomic profiling reveals DNA-methylation changes associated with major psychosis.
Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L
Am J Hum Genet. 2008; 82(3):696-711.
PMID: 18319075
PMC: 2427301.
DOI: 10.1016/j.ajhg.2008.01.008.
Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review.
Watis L, Chen S, Chua H, Chong S, Sim K
J Neural Transm (Vienna). 2008; 115(3):493-511.
PMID: 18301955
DOI: 10.1007/s00702-007-0859-5.
Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia.
Oni-Orisan A, Kristiansen L, Haroutunian V, Meador-Woodruff J, McCullumsmith R
Biol Psychiatry. 2007; 63(8):766-75.
PMID: 18155679
PMC: 2669959.
DOI: 10.1016/j.biopsych.2007.10.020.
Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.
McCullumsmith R, Kristiansen L, Beneyto M, Scarr E, Dean B, Meador-Woodruff J
Brain Res. 2006; 1127(1):108-18.
PMID: 17113057
PMC: 2900828.
DOI: 10.1016/j.brainres.2006.09.011.
N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives.
Millan M
Psychopharmacology (Berl). 2005; 179(1):30-53.
PMID: 15761697
DOI: 10.1007/s00213-005-2199-1.